What is the equity of Wize Pharma this year?
Wize Pharma has equity of 0 USD this year.
Wize Pharma Equity 2025
Wize Pharma Equity
0 USD
Ticker
WIZP
ISIN
US97751M2070
In 2025, Wize Pharma's equity was 0 USD, a 0% increase from the 0 USD equity in the previous year.
Wize Pharma Aktienanalyse
What does Wize Pharma do?
Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Wize Pharma's Equity
Wize Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Wize Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Wize Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Wize Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Wize Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Wize Pharma stock
What was the equity of Wize Pharma compared to the previous year?
The equity of Wize Pharma has increased/decreased by 0% decreased compared to the previous year.
What impact does a high equity have on investors of Wize Pharma?
A high equity is advantageous for investors of Wize Pharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Wize Pharma?
A low equity can be a risk for investors of Wize Pharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Wize Pharma affect the company?
An increase in equity of Wize Pharma can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Wize Pharma affect the company?
A reduction in equity of Wize Pharma can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Wize Pharma?
Some factors that can affect the equity of Wize Pharma include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Wize Pharma so important for investors?
The equity of Wize Pharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Wize Pharma take to change the equity?
To change equity, Wize Pharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Wize Pharma pay?
Over the past 12 months, Wize Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Wize Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Wize Pharma?
The current dividend yield of Wize Pharma is .
When does Wize Pharma pay dividends?
Wize Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Wize Pharma?
Wize Pharma paid dividends every year for the past 0 years.
What is the dividend of Wize Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Wize Pharma located?
Wize Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Wize Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Wize Pharma from 1/29/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/29/2025.
When did Wize Pharma pay the last dividend?
The last dividend was paid out on 1/29/2025.
What was the dividend of Wize Pharma in the year 2024?
In the year 2024, Wize Pharma distributed 0 USD as dividends.
In which currency does Wize Pharma pay out the dividend?
The dividends of Wize Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Wize Pharma
Our stock analysis for Wize Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wize Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
